| 000 | 01707 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516012857.0 | ||
| 264 | 0 | _c20110401 | |
| 008 | 201104s 0 0 eng d | ||
| 022 | _a1473-4877 | ||
| 024 | 7 |
_a10.1185/03007995.2010.536208 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDomingo, Christian | |
| 245 | 0 | 0 |
_aOmalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients. _h[electronic resource] |
| 260 |
_bCurrent medical research and opinion _cJan 2011 |
||
| 300 |
_a45-53 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Anti-Idiotypic |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin E _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOmalizumab |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aMoreno, Amalia | |
| 700 | 1 | _aJosé Amengual, Ma | |
| 700 | 1 | _aMontón, Concepción | |
| 700 | 1 | _aSuárez, David | |
| 700 | 1 | _aPomares, Xavier | |
| 773 | 0 |
_tCurrent medical research and opinion _gvol. 27 _gno. 1 _gp. 45-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1185/03007995.2010.536208 _zAvailable from publisher's website |
| 999 |
_c20380236 _d20380236 |
||